OKYO Pharma (OKYO) Change in Cash (2024 - 2026)

OKYO Pharma's (OKYO) quarterly Change in Cash came in at $12.2 million in Q1 2026, up 729.1% quarter-over-quarter from -$1.9 million in Q4 2025.

Analysis

OKYO Pharma (OKYO) Change in Cash (2024 - 2026) Analysis & Trends

OKYO Pharma (OKYO) has reported Change in Cash for 3 consecutive years, with $12.2 million the latest figure, recorded in Q1 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Cash (Qtr)
1	Amgen	211.73 Bn	197.74 Bn	7.24 Bn	1.95 Bn
2	Gilead Sciences	180.92 Bn	177.74 Bn	6.22 Bn	-4.45 Bn
3	Vertex Pharmaceuticals	132.16 Bn	124.30 Bn	2.84 Bn	649.20 Mn
4	Regeneron Pharmaceuticals	82.89 Bn	74.90 Bn	3.93 Bn	-504.60 Mn
5	Argenx Se	61.41 Bn	56.23 Bn	1.37 Bn	-
6	Moderna	53.99 Bn	48.85 Bn	52.00 Mn	-185.00 Mn
7	Alnylam Pharmaceuticals	34.48 Bn	31.18 Bn	992.69 Mn	-2.94 Mn
8	Biogen	31.15 Bn	29.86 Bn	1.96 Bn	-2.09 Bn
9	Roivant Sciences	30.05 Bn	30.05 Bn	1.16 Mn	-170.44 Mn
10	OKYO Pharma	985.60 Mn	985.60 Mn	-	12.24 Mn

Historic Data

Download Data